- Joined
- Nov 26, 2013
- Messages
- 1,352
- Reaction score
- 193
I'm still having trouble with these two terms. Sorry language isn't really my stronghold.
So the way Kaplan neuroanatomy explains is that when you have a UMN lesion you get a spastic weakness (ipsilateral) and with LMN lesions, you get a flaccid weakness or paralysis.
So how exactly the term spastic different from flaccid? Clinically would you be able to tell?
Also, in micro, I noticed that C. botulinum is associated with flaccid paralysis, which I think it makes sense since the botulinum toxin blocks the ACh release, so it's as if you have a UMN lesion, correct?
However, C. tetani which blocks the release of inhibitory mediators such as glycine and GABA result in extreme muscle spasm so called rigid paralysis. So would this be similar to the spastic weakness we see from UNM lesion since UMN sort of acts as an inhibitory to LMN, right?
Many thanks in advance.
So the way Kaplan neuroanatomy explains is that when you have a UMN lesion you get a spastic weakness (ipsilateral) and with LMN lesions, you get a flaccid weakness or paralysis.
So how exactly the term spastic different from flaccid? Clinically would you be able to tell?
Also, in micro, I noticed that C. botulinum is associated with flaccid paralysis, which I think it makes sense since the botulinum toxin blocks the ACh release, so it's as if you have a UMN lesion, correct?
However, C. tetani which blocks the release of inhibitory mediators such as glycine and GABA result in extreme muscle spasm so called rigid paralysis. So would this be similar to the spastic weakness we see from UNM lesion since UMN sort of acts as an inhibitory to LMN, right?
Many thanks in advance.